# Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy

> **NCT01854593** · PHASE4 · COMPLETED · sponsor: **Nihon University** · enrollment: 69 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy
- Diabetic Traction Retinal Detachment
- Vitreous Hemorrhage

## Interventions

- **DRUG:** Bevacizumab
- **PROCEDURE:** Vitrectomy
- **DEVICE:** Sham injection

## Key facts

- **NCT ID:** NCT01854593
- **Lead sponsor:** Nihon University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-08
- **Final completion:** 2014-03
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854593, "Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01854593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*